First Time Loading...
I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 1.44 USD 3.6% Market Closed
Updated: May 29, 2024

Immuneering Corp
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Immuneering Corp
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
I
Immuneering Corp
NASDAQ:IMRX
Accounts Payable
$2.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$31.3B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$622m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$1.6B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$351.4m
CAGR 3-Years
40%
CAGR 5-Years
34%
CAGR 10-Years
22%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$671.3m
CAGR 3-Years
7%
CAGR 5-Years
23%
CAGR 10-Years
35%

See Also

What is Immuneering Corp's Accounts Payable?
Accounts Payable
2.1m USD

Based on the financial report for Dec 31, 2023, Immuneering Corp's Accounts Payable amounts to 2.1m USD.

What is Immuneering Corp's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
12%

Over the last year, the Accounts Payable growth was -34%. The average annual Accounts Payable growth rates for Immuneering Corp have been 12% over the past three years .